A detailed history of William B. Walkup & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, William B. Walkup & Associates, Inc. holds 11,641 shares of ABT stock, worth $1.33 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
11,641
Previous 11,619 0.19%
Holding current value
$1.33 Million
Previous $1.21 Billion 9.93%
% of portfolio
0.82%
Previous 0.79%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $2,201 - $2,598
22 Added 0.19%
11,641 $1.33 Billion
Q2 2024

Aug 15, 2024

BUY
$100.73 - $112.44 $1.17 Million - $1.31 Million
11,619 New
11,619 $1.21 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track William B. Walkup & Associates, Inc. Portfolio

Follow William B. Walkup & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William B. Walkup & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on William B. Walkup & Associates, Inc. with notifications on news.